The U.S. Government Accountability Office (GAO) has highlighted regulatory uncertainty surrounding engineered biofertilizers, warning that unclear definitions and outdated frameworks could hinder adoption and innovation. The findings, published in March 2026, underscore growing interest in these microbial-based agricultural inputs, which could reduce fertiliser costs and improve yields across the chemicals and agri-food value chain.
Engineered biofertilizers, which use genetically modified microbes to enhance nutrient availability in soils, are gaining attention as a potential alternative to conventional chemical fertilisers. However, the GAO notes that current U.S. regulations may not adequately address these products, creating compliance risks for manufacturers and uncertainty for investors and downstream users.
A central issue is the absence of a clear regulatory definition for biofertilizers. This ambiguity makes it difficult to determine whether existing laws, such as pesticide or biotechnology regulations, apply.
The report cites enforcement risks, including a $300,000 penalty issued by the Environmental Protection Agency in 2020 for an unregistered product. This illustrates the financial and legal exposure facing companies operating in this space.
More critically, regulators may lack the tools to assess genetically engineered microbes. The GAO warns that this could impose burdensome approval processes and slow innovation, potentially affecting U.S. competitiveness in a rapidly expanding global market.
Chemical fertilisers account for up to 45 percent of input costs for some crops, making cost reduction a key driver for alternatives. Engineered biofertilizers could increase crop yields by 5 to 20 percent, although performance varies by region and crop type.
The U.S. biofertilizer market reached $640 million in 2025 and is projected to double by 2031. However, this remains small compared with the $39 billion chemical fertiliser market, highlighting both growth potential and competitive pressure.
Biofertilizers improve nutrient uptake by converting soil elements such as phosphorus and potassium into plant-accessible forms. The diagram on page 2 shows additional mechanisms, including nitrogen fixation and hormone production that supports plant resilience.
Reduced reliance on synthetic fertilisers can also mitigate runoff, lowering the risk of algal blooms and water pollution. This aligns with tightening environmental regulations and sustainability targets across the chemicals sector.
Despite their potential, adoption remains uneven. Brazil uses biofertilizers on over 90 percent of soybean acreage, compared with just 15 percent in the U.S., with estimated annual savings exceeding $15 billion.
Key barriers include uncertain cost effectiveness and limited farmer awareness. A 2023 survey found that broader uptake depends on clearer evidence of profitability and performance under real-world conditions.
Stakeholders across manufacturing, distribution, and regulatory affairs should monitor evolving definitions and guidance. Early engagement with regulators and investment in field validation data will be critical to secure market access and compliance.
The SUPER BUGS Act 2026 establishes a global framework for pandemic product development, targeting antimicrobial resistance and international collaboration. It introduces regulatory, commercial, and supply chain implications for chemicals and manufacturing stakeholders, reinforcing the need for proactive compliance and strategic positioning.
In May 2023, the EPA reviewed two suspicious studies conducted at Palamur, leading to concerns about possible data falsification.
These amendments will permit the continued sale and distribution of existing stocks of these specified products until predetermined deadlines.
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at
